From Nu-Forme Labs

Nu-Forme Labs research articles for practical ordering, clear payment expectations, and value-aware shopping.

Woman in her late fifties rests beside a barbell in a gym between strength sets

Article

Does Tirzepatide Muscle Loss Mean Losing Strength?

Tirzepatide trials show large weight changes, but muscle loss is harder to interpret. Here is what body-composition scans actually measured, and what they did not.

Read article

Empty swimming pool lanes from above in early morning light.

Article

What Incretin Trials Measure Beyond Weight Loss

Large incretin trials measure more than pounds lost. Here is what tirzepatide studies track, what they miss, and why midlife readers should look past the scale.

Read article

Midlife woman tying walking shoes by the front door in soft morning light.

Article

Weight-Loss Trials Beyond The Scale: What They Measure

Modern weight-loss trials report more than pounds lost. Here is what they measure, what retatrutide data show so far, and what remains unknown for midlife readers.

Read article

Midlife woman walking a dog at dawn on a quiet sidewalk.

Article

Why Weight Regain Happens After Tirzepatide Trials Stop

Randomized withdrawal trials show that weight often returns when incretin treatment stops. The harder question is whether that is personal failure, biology, or both.

Read article

Woman in soft morning window light touching her cheek thoughtfully.

Article

Can Skin Elasticity Improve With Oral Collagen?

Skin elasticity can be measured with instruments, not just judged in the mirror. Human trials of oral collagen peptides show modest changes, but the evidence is short-term and mostly industry-funded.

Read article

Warm laboratory bench scene with glassware and research equipment

Article

What Clinical Studies Say About Tirzepatide Weight Loss Maintenance

Large phase 3 trials show tirzepatide weight loss can be substantial while treatment continues, with regain after withdrawal. The evidence is strong for the trial populations, but menopause-specific reporting is thin.

Read article

Clinical trial documents and endpoint chart representing bremelanotide research in women.

Article

What Clinical Studies Say About Bremelanotide and Low Sexual Desire in Women

A close read of bremelanotide clinical studies in women: who was enrolled, what endpoints were measured, what improved, what did not, and why the data leave major gaps for perimenopause and menopause.

Read article

Abstract clinical trial comparison graphic showing two peptide structures and metabolic endpoint charts.

Article

Retatrutide vs Tirzepatide: Comparing the Latest Clinical Evidence

Retatrutide and tirzepatide are often compared, but the evidence is not evenly mature. This review looks at what human trials actually measured, where the endpoints overlap, and where the comparison stops.

Read article